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 Introduction 
 Osteogenesis imperfecta (OI) or brittle bone disease, 
first described by Ekman in 1788, is a heterogeneous 
group of inherited connective tissue disorders character-
ized by an increased bone fragility and low bone mass  [1] . 
OI results from either a reduction of the normal type I 
collagen production (mildest form, type I OI) or from an 
abnormal collagen type 1 synthesis.
 Four different types of OI are distinguished  [2, 3] . 
Type I is the most frequent form ( 1 60% of patients). Clin-
ical symptoms are usually mild; children rarely suffer 
from skeletal deformities, hearing loss often occurs (50% 
of families). Type II is the most severe, invariable lethal 
form. The main death courses are severe bone fragility, 
complications from infection in hypoplastic lungs, respi-
ratory distress syndrome, cardiac insufficiency, or cere-
bral injury. Children with type III and IV OI who survive 
the neonatal period suffer however from significant com-
plications. Recently, a type V and VI as well as a rhizo-
melic OI have been identified by clinical and molecular 
analysis  [3, 4] .
 Prenatal ultrasonography (US) is the first modality of 
choice for detecting fetal pathologies including OI. Mag-
netic resonance imaging (MRI) serves as a second-line 
imaging modality to confirm, correct or complete US 
findings  [3, 5, 6] . Fetal MRI is especially advantageous 
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 Abstract 
 We describe the prenatal magnetic resonance imaging (MRI) 
findings in a 25-week-old fetus with proven osteogenesis 
imperfecta type II. Fetal MRI findings are correlated with pre-
natal ultrasonography, conventional x-ray fetography and 
postpartal findings. Fetal MRI proves to be superior to con-
ventional fetography in the evaluation of the skeletal find-
ings. The high soft tissue resolution, the large field of view 
and the multiplanar imaging make it possible to study the 
non-ossified fetal skeleton in detail. Compared to prenatal 
ultrasonography, fetal MRI gives important additional infor-
mation about the expected lung functionality by estimating 
fetal lung volume and signal intensity and rules out possible 
additional abnormalities of major fetal organs. These param-
eters may serve as valuable, additional prognostic markers 
in the prenatal diagnostic work-up. 
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because of its high spatial and soft tissue resolution, the 
high T 2 contrast between fluid and solid tissue, the large 
field of view and the absence of obscuring maternal bow-
el gas or pelvic bony structure artifacts  [7] . During the 
last decade, molecular diagnosis including structure 
analysis of collagen molecules in cultured fibroblasts ob-
tained from chorion villus sampling and amniocytes as 
well as genomic DNA screening has become an useful 
tool in the diagnostic work-up of suspected skeletal dys-
plasia. These tests are however not widely available and 
time-consuming.
 We present the prenatal fetal MRI findings in a case of 
OI type II. Fetal MRI findings are correlated with prena-
tal conventional fetography (CF) and postnatal findings.
 Case Report 
 A 37-year-old primigravida woman was referred to our hospi-
tal for CF and possible fetal MRI because routine prenatal US ex-
amination at 24 weeks’ gestation had suspected skeletal dysplasia. 
US findings included reduced acoustic shadowing, bowing and 
shortening of the long bones and a small fetal chest circumfer-
ence. Differential diagnosis included thanatophoric dwarfism 
and OI. No additional fetal pathology was identified.
 The family history was uneventful, pregnancy was unremark-
able. The mother was healthy and denied being exposed to drugs 
relevant to the pregnancy.
 CF showed a small osteopenic skull. The degree of skeletal os-
teopenia was so severe that CF failed to delineate the remainder 
of the fetal skeleton. This phenomenon is also known as ‘the in-
visible fetus’ appearance ( fig. 1 ).
 Because CF failed to establish a definite diagnosis, ultrafast 
fetal MRI was performed using a 1.5-T MRI unit (Signa Excite II, 
General Electric Healthcare, Milwaukee, Wisc., USA). Imaging 
was acquired according to the routine departmental protocol. A 
multiplanar T 2 -weighted single-shot fast spin-echo as well as T 1 -
weighted gradient echo sequences of the fetus were acquired using 
an 8-channel phase array cardiac surface coil  [8] . No maternal or 
fetal sedation was administered. The entire fetus, placenta and 
maternal uterus were studied.
 MRI revealed significantly shortened and bowed extremities 
with normal hands and feet ( fig. 2 a, b). The thorax was small in 
size with a dumbbell shape. The volumetric measurements of the 
fetal lungs, using a previously published method, showed signifi-
cantly reduced lung volumes (9.1 ml) (28% of the expected, age-
corrected lung volume: 32.9 ml)  [9] . In addition, the T 2 signal 
intensity was significantly reduced indicating lung hypoplasia 
( fig. 2 a, b). No additional abnormalities were seen: the brain, spi-
nal cord, vertebral column and abdominal organs were unre-
markable. The amount of amniotic fluid was normal. The pla-
centa and umbilical cord were normal in size without any pathol-
ogy.
 Based on the fetal MRI findings in combination with the ‘in-
visible fetus’ appearance on CF, OI type II was postulated. Prog-
nosis was estimated as being poor. The parents were informed 
about the suspected diagnosis and counseled about the likely le-
thal outcome. The parents decided to terminate pregnancy which 
was performed 1 week later during the 25th week of gestation.
 Post-mortem examination (autopsy) confirmed prenatal diag-
nosis. Macro- and microscopic inspection showed significant 
growth retardation, multiple fractures of the long bones and ribs, 
hypermobility of the elbows and hip joints as well as a significant 
lung hypoplasia ( fig. 3 a, b). Postnatal conventional radiography 
showed the classical features of type II OI with deformation of all 
extremities due to multiple fractures as well as a small, narrowed, 
dumbbell-shaped thorax ( fig. 4 ), triangular face with beaked 
nose, and typical frog-like position. Chromosomal analysis re-
vealed a 46,XX karyotype without chromosomal abnormalities.
 Discussion 
 OI is a group of inherited connective tissue disorders 
where the basic pathology is defective collagen matura-
tion. The incidence of OI varies from 1 in 20,000 to 1 in 
60,000 and is more common in female fetuses  [2, 10] . In 
the vast majority of cases (95% of patients with definite 
diagnosis), OI is caused by dominant mutations in the 
gene encoding for the type I procollagen (COL1A1 and 
COL1A2). In the meantime, more than 400 different 
causal mutations have been published and reported in the 
Human Type I Collagen Mutation Database (www.le.ac.
uk/genetics/collagen/index.thml)  [11, 12] .
 Individuals with OI have a 25% (type II, III) to 50% 
(type I, IV) chance of transmitting the disease to their 
offspring and therefore genetic counseling and prenatal 
diagnosis should be offered to all affected patients. The 
a b
 Fig. 1. Conventional AP and lateral oblique fetography: The fetal 
skull can be faintly delineated within the maternal pelvis (ar-
rows). The remainder of the fetal skeleton is too osteopenic to be 
delineated: ‘invisible fetus’ phenomenon. 
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a
b
 Fig. 2.  a Sagittal T 2 -weighted single-shot fast spin-echo MR im-
ages of the fetus: the shortened and widened long bones are easily 
identified within the upper and lower extremities (arrows). In ad-
dition, the fetal lungs are small in size and significantly T 2 -hy-
pointense (arrowheads) indicating lung hypoplasia. The remain-
der of the fetal anatomy is without pathology. The images have 
been flipped top to bottom.  b Coronal T 2 -weighted single-shot 
fast spin-echo MR images of the fetus: the shortened and widened 
long bones are easily identified within the upper extremities that 
are folded in front of the fetus (arrows). In addition, a small dumb-
bell-shaped thorax with T 2 -hypointense and small lungs are dis-
played (arrowheads). 
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risk of recurrence in healthy parents who have an affect-
ed offspring arises from parental germline mosaicism 
and is estimated at 5–8%  [13–15] .
 Skeletal manifestations result from a generalized defi-
ciency of membranous and endochondral bone develop-
ment due to abnormal collagen production and include 
markedly thinned calvarium with delayed closure of fon-
tanelles, sutures and excessive wormian bone formation 
resulting in the brittleness of OI bone. The most frequent 
extraskeletal manifestations include the blue sclerae, 
dentinogenesis imperfecta, hyperlaxity of the ligaments, 
and progressive hearing loss. The spectrum of the disease 
varies widely: children may present with only a mild os-
teoporosis (type I OI), while the most severe cases may be 
lethal early within the neonatal period (type II OI). 
 According to the most widely used classification [16], 
OI is classified into four types: type I–IV. Recently, OI 
type V, VI and rhizomelic OI have been added to the clas-
sification ( table 1 )  [3, 11] . These additional types of OI 
have been identified on the basis of recent clinical and 
molecular findings. OI is also grouped into two classes: 
deforming and non-deforming bone disease. This arbi-
trary grouping can be helpful for correlating clinical phe-
notype with underlying genetic and pathophysiological 
findings  [17] .
 Fig. 3.  a, b Post-mortem examination of the fetus confirms short-
ened and bowed upper and lower extremities. The chest volume 
is too small. The fetus is in the typical ‘frog-like’ position. 
a
b
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 Fig. 4. Post-mortem conventional AP fetography: multiple frac-
tures are seen along the widened, bowed and deformed long bones 
of the upper and lower extremities. In addition, multiple fractures 
are seen within the ribs with resulting small chest volume and 
hypoplastic lungs. The entire fetal skeleton is significantly os-
teopenic. 
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 Type II OI is the most severe, invariable lethal form of 
OI. Most children die within the perinatal period. Death 
usually occurs in the neonatal period due to complica-
tions from infection, respiratory distress, cardiac insuf-
ficiency, or cerebral injury  [6] . Newborns present with 
soft calvarian bones, peculiar triangular-shaped face 
with a beaked nose and blue sclera  [6] . Clinical examina-
tion usually shows short, deformed extremities due to 
multiple fractures and a typical ‘frog-like’ position. In ad-
dition to the well-defined skeletal anomalies in type II 
OI, associated central nervous system (CNS) findings 
have been shown including vascular microcalcifications 
and migrational defects  [2, 18] .
 Diagnosis of OI as early as possible during pregnancy 
is essential to guide pregnancy and to counsel parents. 
Molecular testing procedures, such as RNA and protein 
analysis of fibroblasts and genomic DNA analysis from 
extracted blood, are available to identify the presence of 
mutation and may prove beneficial in the prenatal diag-
nosis of the lethal OI (type II) as well as in the evaluation 
of the milder OI type I cases. Molecular testing may also 
be beneficial if child abuse is suspected. However, up-to-
date molecular diagnosis is not available in every institu-
tion and the screening of type I collagen genes cannot 
cover the whole clinical range of OI since the recently de-
scribed forms (type V, VI, rhizomelic OI) have their caus-
al mutations in yet unknown loci.
 Currently, prenatal screening and diagnosis of OI is 
based on the so-called characteristic sonographic and ra-
diological findings.
 In the absence of a previous history of OI, fetal mor-
phological examination by prenatal US remains the 
screening method of choice for antenatal diagnosis of 
OI.
 Sonographic features include a reduced acoustic shad-
owing of long bones, marked bowing and shortening of 
long bones and an increased nuchal translucency in early 
pregnancy  [5] . First trimester prenatal diagnosis of iso-
lated OI has been reported as early as 12–14 weeks of ges-
tation  [19] . Although the sensitivity of US performed at 
18–22 weeks of gestation for detecting lethal skeletal dys-
plasia is estimated as being high (94–96% and 70% for 
detection of the major limb abnormalities), it is of limited 
value to provide the accurate diagnosis (30–50%)  [20] . 
Despite the fact that several sonographic criteria (e.g. 
presence of shortened, curved femora and a small chest) 
have been used to distinguish the non-lethal forms from 
the lethal of skeletal dysplasia (including OI type II), a 
significant proportion, 7.8% of fetuses with prenatally es-
tablished skeletal dysplasia, are misdiagnosed  [21] . US is 
also limited in the detection of the mild forms of OI and 
the detailed evaluation of additional abnormalities, espe-
cially in the identification of the degree of associated pul-
monary hypoplasia, which may determine prognosis  [10, 
22] .
 Recent studies have suggested the potential advantage 
of using three-dimensional US to improve the accuracy 
of prenatal diagnosis. Three-dimensional US suffers 
however from the well-known limitations of US which 
include unfavorable fetal position, maternal obesity, ob-
scuring pelvic bones and maternal bowel gas and the lim-
ited field of view  [6] . In addition, three-dimensional pre-
natal US cannot give adequate information about the 
maturation of the fetal lungs.
 Conventional radiography (fetography), initially used 
for the antenatal diagnosis of OI, is nowadays rarely used. 
The main conventional radiological features are bowing 
(camptomelia) and shortening of the limbs and narrow-
ing of the thorax due to multiple rib fractures. Extreme 
radiolucency of the fetal skeleton may result in the radio-
logical phenomenon of an ‘invisible fetus’  [3, 12] .
Table 1. Classification of OI [1, 4–6, 11]
Molecular
classification
Clinical
classification
Clinical severity Fracture
frequency
Dentinogenesis 
imperfecta
Hearing
loss
Sclera’s color
Dominant negative type II perinatal, lethal progressive ++++ –/+ + intensive blue
Dominant negative type III deforming moderate +++ –/+ + light blue
Dominant negative type IV deforming moderate +/++ –/+ + white
? type V deforming moderate to severe ++/+++ –/+ – white/faintly blue
? type VI deforming moderate to severe ++/+++ – – white/faintly blue
? rhizomelic OI deforming ++/+++ –(?) –(?) (?)
Haploid insufficiency type I classical mild OI –/+ –/+ +++ intensive blue
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